Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa.
Where this comes from
- Record sourced from PubMed, PMID 39375336.
- Also identified by DOI 10.1038/s41467-024-53126-3 and PMC identifier 11458601.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the <u>Con</u>sortium for <u>C</u>OVID-19 <u>Va</u>ccine <u>C</u>linical <u>T</u>rials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.
Medical subject headings
- COVID-19
- Pandemics
- Clinical Trials as Topic